With additional genome variations, our current WGS study further strengthened this finding, as co-selected NF-κB-activating mechanisms in 90% (63/70) of this tumor cohort with a high degree of mutual exclusivity (two-sided Fisher’s exact test p = 7.4 × 10−7). This evidence concerns the gene NFKB1 and neoplasm.